References
- World Health Oarganaisation. Hepatitis C. J. 2024. 16.
- Taha G, Ezra L, Abu-Freha N. Hepatitis C elimination: opportunities and challenges in 2023. Viruses. 2023;15(7, Art. no. 7):1413. doi:10.3390/v15071413
- Sonderup MW, Afihene M, Ally R, et al. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. Lancet Gastroenterol Hepatol. 2017;2(12):910–919. doi:10.1016/S2468-1253(17)30249-2
- Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J. 2013;14(44, Art. no. 44). doi:10.11604/pamj.2013.14.44.2199
- de Oliveria Andrade LJ, D’Oliveira A, Melo RC, De Souza EC, Costa Silva CA, Paraná R. Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis. 2009;1(1):33–37. doi:10.4103/0974-777X.52979
- “Pathogenesis of hepatitis C virus-related hepatocellular carcinoma: evidence from recent studies - Maruyama - Journal of Public Health and Emergency”.: Jan. 16, 2024. [Online]. Available: https://jphe.amegroups.org/article/view/7483/html.
- Hepatitis C virus and hepatocellular carcinoma: a narrative review - PMC. J. 2024;16. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863002/.
- Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa | request PDF. ResearchGate. 2023. doi:10.1111/tme.12988
- Hasan Mohamed El-Sagheer S, Castro O, Giday SA, “HCV in sickle cell disease”. Accessed: Jan. 16, 2024. [Online]. Available: https://www.researchgate.net/publication/9065255_HCV_in_sickle_cell_disease.
- “Trends of the global hepatitis C disease burden: Strategies to achieve elimination”. Accessed: Jan. 16, 2024. [Online]. Available: https://www.jpmph.org/journal/view.php?number=2154.
- Seu R, et al. Challenges and best practices for hepatitis c care among people who inject drugs in resource limited settings: focus group discussions with healthcare providers in Kenya. Glob Public Health. 2022;17(12):3627. doi:10.1080/17441692.2022.2110919
- Mohd Suan MA, Said SM, Lim PY, Azman AZF, Abu Hassan MR. Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: a case–control study. PLoS One. 2019;14(10):e0224459. doi:10.1371/journal.pone.0224459
- Nurutdinova D, Abdallah AB, Bradford S, O’Leary CC, Cottler LB, “Risk factors associated with hepatitis C among female substance users enrolled in community-based HIV prevention studies - PMC”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095996/.
- WHO Africa region, “Hepatitis Scorecard for the WHO Africa region implementing the hepatitis elimination strategy”, WHO | Regional Office for Africa. Accessed: Jan. 17, 2024. [Online]. Available: https://www.afro.who.int/publications/hepatitis-scorecard-who-africa-region-implementing-hepatitis-elimination-strategy.
- WHO Africa, “New WHO scorecard shows poor progress of the viral hepatitis response in the African region”, WHO | Regional Office for Africa. Accessed: Jan. 17, 2024. [Online]. Available: https://www.afro.who.int/news/new-who-scorecard-shows-poor-progress-viral-hepatitis-response-african-region.
- Hopkins University J, Baltimore MDUSA, “Progress towards elimination goals for viral hepatitis - PMC”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376316/.
- Popping S, Bade D, Boucher C, et al. The global campaign to eliminate HBV and HCV infection: international viral hepatitis elimination meeting and core indicators for development towards the 2030 elimination goals. J Virus Erad. 2019;5(1):60. doi:10.1016/S2055-6640(20)30281-8
- WHO, “Access to treatment and care for all: the path to eliminate hepatitis C in Egypt”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.who.int/news-room/feature-stories/detail/access-to-treatment-and-care-for-all--the-path-to-eliminate-hepatitis-c-in-egypt.
- Hassanin A, “Egypt’s ambitious strategy to eliminate hepatitis C Virus: A case study - PMC”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087425/.
- Ammal M. Metwally, “accelerating hepatitis C virus elimination in Egypt by 2030: a national survey of communication for behavioral development as a modelling study - PMC”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901784/.
- Ismail KH, Iii DEL-P. The need to re-invigorate initiatives against Hepatitis C in Egypt. Popul Med. 2023;5(February):1–2. doi:10.18332/popmed/160080
- Hassany M, Abdel-Razek W, AbdAllah M, “WHO awards Egypt with gold tier status on the path to eliminate hepatitis C - the lancet gastroenterology & hepatology”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00364-3/fulltext.
- Azevedo MJ, “The state of health system(s) in Africa: challenges and opportunities - PMC”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123888/.
- Schröeder SE, Pedrana A, Scott N, et al. Innovative strategies for the elimination of viral hepatitis at a national level: a country case series. Liver Int. 2019;39(10):1818–1836. doi:10.1111/liv.14222
- Daw MA, 2024,*Abdallah El-Bouzedi, 2 Mohamed O. Ahmed, 3 Aghnyia A. Dau, 4 and Mohamed M. Agnan 5, “Hepatitis C Virus in North Africa: an Emerging Threat - PMC”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004010/.
- IIHME. Global Burden of Disease Study. 2019; Available from: https://ourworldindata.org/grapher/hepatitis-c-number-of-deaths?region=Africa.
- Raad I, Chaftari A-M, Torres HA, et al. Challenge of hepatitis C in Egypt and hepatitis B in Mauritania. World J Hepatol. 2018;10:549–557. doi:10.4254/wjh.v10.i9.549
- WHO, “WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.who.int/news/item/25-06-2021-who-releases-first-ever-global-guidance-for-country-validation-of-viral-hepatitis-b-and-c-elimination.
- WHO, “Manual for the development and assessment of national viral hepatitis plans”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.who.int/publications/i/item/9789241509350.
- The Opportunity to Eliminate Hepatitis C through Alternative Financing Mechanisms. J. 2024;17. [Online]. Available: https://endhep2030.org/wp-content/uploads/2022/06/Policy-Brief_HCV.pdf.
- Klein F. 100 million seha: Egypt’s war against hepatitis C. PharmaBoard. 2024;17. [Online]. Available https://pharmaboardroom.com/articles/100-million-seha-egypts-war-against-hepatitis-c/.
- WHO, “WHO commends Egypt for its progress on the path to eliminate hepatitis C”. Accessed: Jan. 17, 2024. [Online]. Available: https://assumption-prod.modolabs.net/parents__families/au_news/detail?feed=wr_crisis_response_who_news&id=7a0bad49-4b30-55eb-be91-6f9af408d33c&_kgoui_bookmark=f0f0ee60-484b-5273-9b0d-3c0e7b37a3fa.Accessed May 28 2024.
- WHO, “Egypt becomes the first country to achieve WHO validation on the path to elimination of hepatitis C”, World Health Organization - Regional Office for the Eastern Mediterranean. Accessed: Jan. 17, 2024. [Online]. Available: http://www.emro.who.int/media/news/egypt-becomes-the-first-country-to-achieve-who-validation-on-the-path-to-elimination-of-hepatitis-c.html.
- Jordano J, Curkovic N, Aggarwal S, Hutcheson K, “(PDF) hepatitis C treatment for patients without insurance in a student-run free clinic: analysis of demographics, cost, and outcomes”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.researchgate.net/publication/374954336_Hepatitis_C_Treatment_for_Patients_Without_Insurance_in_a_Student-Run_Free_Clinic_Analysis_of_Demographics_Cost_and_Outcomes.Accessed May 28 2024
- Elbahrawy A, Ibrahim MK, Eliwa A, Alboraie M, Madian A, Aly HH. Current situation of viral hepatitis in Egypt. Microbiol Immunol. 2021;65(9):352–372. doi:10.1111/1348-0421.12916
- Deress T, Million Y, Belachew T, Jemal M, Girma M. Seroprevalence of hepatitis c viral infection in Ethiopia: a systematic review and meta-analysis. Sci World J. 2021;2021:e8873389. doi:10.1155/2021/8873389
- “prevalence of hepatitis B and hepatitis C in migrants from sub-saharan Africa before onward dispersal toward Europe | Journal of Immigrant and Minority Health”. Accessed: Jan. 17, 2024. [Online]. Available: https://link.springer.com/article/10.1007/s10903-022-01448-z.
- WHO, “Prevention and control of viral hepatitis infection: Framework for global action”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.who.int/publications-detail-redirect/prevention-and-control-of-viral-hepatitis-infection-framework-for-global-action.
- “Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges | future virology”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.futuremedicine.com/doi/10.2217/fvl.13.11.
- “The art and science of eliminating hepatitis: Egypt’s experience”. Accessed: Jan. 17, 2024. [Online]. Available: https://www3.weforum.org/docs/WEF_The_Art_and_Science_of_Eliminating_Hepatitis_Egypt’s_Experience_2022.pdf.
- Margaret H, Sophia E S, Pedrana A, “The elimination of hepatitis c as a public health threat - PMC”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117951/.
- Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824–7840. doi:10.3748/wjg.v22.i34.7824
- ministry of health Malaysia, “National Institutes of Health - NIH official portal”. Accessed: Jan. 17, 2024. [Online]. Available: https://nih.gov.my/.
- Cox AL, El-Sayed MH, Kao J-H, et al., “Progress towards elimination goals for viral hepatitis | nature reviews gastroenterology & hepatology”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.nature.com/articles/s41575-020-0332-6.
- Ha S, Timmerman K. Awareness and knowledge of hepatitis C among health care providers and the public: a scoping review. Can Commun Dis Rep. 2018;44(7–8):157–165. doi:10.14745/ccdr.v44i78a02
- Li T, Wang R, Zhao Y, Su S, Zeng H. Public awareness and influencing factors regarding hepatitis B and hepatitis C in Chongqing municipality and Chengdu City, China: a cross-sectional study with community residents. BMJ Open. 2021;11(8):e045630. doi:10.1136/bmjopen-2020-045630
- WHO, “Consolidated strategic information guidelines for viral hepatitis planning and tracking progress towards elimination: guidelines”. Accessed: Jan. 17, 2024. [Online]. Available: https://www.who.int/publications-detail-redirect/9789241515191.
- I. of M. (US) C. on the P. and C. of V. H. Infection, H. M. Colvin, and A. E. Mitchell, “knowledge and awareness about chronic hepatitis b and hepatitis C. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. National Academies Press (US,2010. [Online]. Available. https://www.ncbi.nlm.nih.gov/books/NBK220038/.Accessed May 28 2024.